Clinical Trials Browser

Phase 2 × Terminated × ARQ 197 × Clear all

NCT02608411 2023-10-13

TIMES

Phase 2 Terminated

Carcinoma, Small Cell

NCT01055067 2021-04-06

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Phase 2 Terminated

27 enrolled 6 charts

Seminoma

NCT01861301 2016-10-24

Tivantinib in Treating Patients With Previously Treated Malignant Mesothelioma

Phase 2 Terminated

18 enrolled 7 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural